Back to Search
Start Over
Ophthalmic manifestations of coronavirus disease 2019 and ocular side effects of investigational pharmacologic agents.
- Source :
-
Current opinion in ophthalmology [Curr Opin Ophthalmol] 2020 Sep; Vol. 31 (5), pp. 403-415. - Publication Year :
- 2020
-
Abstract
- Purpose of Review: To compile and report the ocular manifestations of coronavirus disease 2019 (COVID-19) infection and summarize the ocular side effects of investigational treatments of this disease.<br />Recent Findings: Conjunctivitis is by far the most common ocular manifestation of COVID-19 with viral particles being isolated from tears/secretions of infected individuals. Multiple therapeutic options are being explored across a variety of medication classes with diverse ocular side effects.<br />Summary: Eye care professionals must exercise caution, as conjunctivitis may be the presenting or sole finding of an active COVID-19 infection. While no currently studied therapeutic agents have been found to reliably treat COVID-19, early vaccination trials are progressing and show promise. A video abstract is available for a more detailed summary. VIDEO ABSTRACT: http://links.lww.com/COOP/A36.
- Subjects :
- COVID-19
Conjunctivitis, Viral drug therapy
Conjunctivitis, Viral virology
Drug-Related Side Effects and Adverse Reactions prevention & control
Eye Diseases prevention & control
Humans
Pandemics
SARS-CoV-2
Betacoronavirus isolation & purification
Conjunctivitis, Viral diagnosis
Coronavirus Infections diagnosis
Drug-Related Side Effects and Adverse Reactions etiology
Drugs, Investigational adverse effects
Eye Diseases chemically induced
Pneumonia, Viral diagnosis
Tears virology
Subjects
Details
- Language :
- English
- ISSN :
- 1531-7021
- Volume :
- 31
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Current opinion in ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 32740062
- Full Text :
- https://doi.org/10.1097/ICU.0000000000000682